Appendix cancer differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
(38 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Appendix_cancer]] | |||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | ==Overview== | ||
Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs. | [[Vermiform appendix|Appendix]] [[cancer]] must be [[Appendix cancer differential diagnosis|differentiated]] from [[Benign|benign appendix lesions]] ([[mucocele]], [[Appendicitis|acute appendicitis]]), [[Colorectal cancer|colorectal cancers]], [[Ovarian cancer|adenexal masses]] ([[Ovarian cancer|ovarian tumors]]), and [[Neuroendocrine tumors|carcinoid tumors of the other organs]]. | ||
==Differentiating appendix cancer from other Diseases== | ==Differentiating appendix cancer from other Diseases== | ||
*Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs. | *[[Vermiform appendix|Appendix]] [[cancer]] must be [[Appendix cancer differential diagnosis|differentiated]] from [[Benign|benign appendix lesions]] ([[mucocele]], [[Appendicitis|acute appendicitis]]), [[Colorectal cancer|colorectal cancers]], [[Ovarian cancer|adenexal masses]] ([[Ovarian cancer|ovarian tumors]]), and [[Neuroendocrine tumors|carcinoid tumors of the other organs]]. | ||
*As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. | *As [[appendix cancer]] manifests in a variety of [[clinical]] forms, differentiation must be established in accordance with the particular subtype. | ||
:*Carcinoid tumors must be differentiated from other diseases that | :*[[Carcinoid Tumor|Carcinoid tumors]] must be differentiated from other diseases that cause [[carcinoid syndrome]] sign and symptoms such as [[palpitation]], [[Flushing|facial flushing]], and [[diarrhea]]. | ||
:*In contrast, | :*In contrast, [[adenocarcinoma]]<nowiki/>s and cystadenocarcinomas must be differentiated from other diseases that cause [[Appendicitis|acute appendicitis]] or present with [[pseudomyxoma peritonei]], such as [[Colorectal cancer|colorectal cancers]] and [[Appendix cancer echocardiography and ultrasound|appendix mucoceles]]. | ||
<small> | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
Line 25: | Line 25: | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | ||
pathology | |||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | ||
Line 63: | Line 64: | ||
|- | |- | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix cancer | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix cancer | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adenocarcinoma<small><sup>1</sup></small> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adenocarcinoma|Adeno-]] | ||
[[Adenocarcinoma|carcinoma]]<small><sup>1</sup></small> | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | -/+ | | style="background: #F5F5F5; padding: 5px;" | -/+ | ||
| style="background: #F5F5F5; padding: 5px;" | <math>\downarrow</math> | | style="background: #F5F5F5; padding: 5px;" | <math>\downarrow</math> | ||
| rowspan="1" style="background: #F5F5F5; padding: 5px;" | | | rowspan="1" style="background: #F5F5F5; padding: 5px;" | | ||
* '''Generally asympto-<br>matic''' | * '''Generally [[Asymptomatic|asympto-<br>matic]]''' | ||
* Appendicitis symptoms | * [[Appendicitis]] [[Symptom|symptoms]] | ||
* [[Nausea and vomiting|Nausea<br>&<br>vomiting]],<br> | * [[Nausea and vomiting|Nausea<br>&<br>vomiting]],<br>decreased<br>[[appetite]] | ||
* No gas<br>or<br>stool pass<br>(intestinal<br>obstruction) | * No gas<br>or<br>stool pass<br>([[Bowel obstruction|intestinal<br>obstruction]]) | ||
* Bone pain<br>(bone<br>metastasis) | * [[Bone pain]]<br>(bone<br>[[Metastasis|metastasis)]] | ||
* Bloating<br>(ascites) | * [[Bloating]]<br>([[ascites]]) | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting dullness | * [[Shifting dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
* | * | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Soft<br>tissue<br>thickening | * Soft<br>tissue<br>thickening | ||
* Wall<br> irregularity | * Wall<br> irregularity | ||
* Presence<br>of<br> pseudo-<br>myxoma<br>peritonei | * Presence<br>of<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma<br>peritonei]] | ||
* Calcification | * [[Calcification]] | ||
* Internal<br>septations | * Internal<br>septations | ||
* Peri<br>appendiceal<br>fat<br>stranding<br> | * Peri<br>appendiceal<br>fat<br>stranding<br>and<br>intra-<br>peritoneal<br>free fluid<br> which is a<br> nonspecific<br> finding | ||
* Cystic<br> lesion | * Cystic<br> lesion | ||
* | * | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Diffusion<br>weighted<br>MRI<br>has<br>been<br>shown to<br>be<br>the<br>modality<br>of choice<br>for<br>''peritoneal<br>carcino-<br>matosis'' | * Diffusion<br>weighted<br>[[Magnetic resonance imaging|MRI]]<br>has<br>been<br>shown to<br>be<br>the<br>modality<br>of choice<br>for<br>''[[Peritoneal carcinomatosis|peritoneal<br>carcino-<br>matosis]]'' | ||
* Increased<br>fluid<br>signal on<br>T2 weighted sequence | * Increased<br>fluid<br>signal on<br>T2 weighted sequence | ||
* Soft<br> tissue<br> mass in<br> the<br>[[appendix]] | * Soft<br> tissue<br> mass in<br> the<br>[[appendix]] | ||
Line 104: | Line 106: | ||
* Distinct<br> appendix<br> wall<br> layers | * Distinct<br> appendix<br> wall<br> layers | ||
| style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|Positron<br>emission<br>tomography]]<br>(PET) | | style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|Positron<br>emission<br>tomography]]<br>(PET) | ||
| style="background: #F5F5F5; padding: 5px;" |'''Gross pathology''': | | style="background: #F5F5F5; padding: 5px;" |'''Gross<br>[[pathology]]''': | ||
* Gray/yellow color | * Gray/yellow<br>color | ||
* Cystic structures with angiolymphatic invasion | * Cystic<br>structures<br>with<br>angiolymphatic<br>invasion | ||
* Appendix might be buried within the mass | * [[Vermiform appendix|Appendix]]<br>might be<br>buried<br>within<br>the mass | ||
'''Microscopic pathology:''' | '''Microscopic<br>pathology:''' | ||
* Intestinal, mucinous or signet ring cell types | * Intestinal,<br>mucinous<br>or<br>[[Signet ring cell carcinoma|signet ring<br>cell]] types | ||
* Coexisting acute appendicitis is common | * Coexisting<br>[[Appendicitis|acute<br>appendicitis]]<br>is common | ||
'''IHC | '''[[Immunohistochemistry|IHC]]:''' | ||
* MUC 2 | * MUC 2 | ||
* '''MUC5AC''' | * '''MUC5AC''' | ||
Line 120: | Line 122: | ||
* CK 20 | * CK 20 | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid tumor<sup>2</sup> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Carcinoid Tumor|Carcinoid]] | ||
[[Carcinoid Tumor|tumor]]<sup>2</sup> | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math> | | style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math> | ||
| rowspan="1" style="background: #F5F5F5; padding: 5px;" | | | rowspan="1" style="background: #F5F5F5; padding: 5px;" | | ||
* '''Generally asympto-<br>matic''' | * '''Generally [[Asymptomatic|asympto-<br>matic]]''' | ||
* Flushing | * [[Flushing]] | ||
* Palpitation | * [[Palpitation]] | ||
* Dyspnea | * [[Dyspnea]] | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* TR<br>murmur | * [[Tricuspid regurgitation|TR]]<br>[[Heart murmur|murmur]] | ||
* Wheezing | * [[Wheeze|Wheezing]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Ki67:<br>a reliable<br>marker of<br>cell<br>proliferation | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Somatostatin]]<br>[[scintigraphy]]<br>with<br> 111-indium-<br>octreotide | * [[Somatostatin]]<br>[[scintigraphy]]<br>with<br> 111-indium-<br>octreotide | ||
* [[Bone]]<br>[[scintigraphy]]<br> with<br> 99mTc-<br>methylene<br> diphosphonate<br>(99mTcMDP) | * [[Bone]]<br>[[scintigraphy]]<br> with<br> 99mTc-<br>methylene<br> diphosphonate<br>(99mTcMDP) | ||
* Positron<br>emission<br>tomography<br>(PET) | * Positron<br>emission<br>tomography<br>(PET) | ||
| style="background: #F5F5F5; padding: 5px;" |'''Gross pathology''': | | style="background: #F5F5F5; padding: 5px;" |'''Gross<br>[[pathology]]''': | ||
* | * [[Prevalence|Prevalent]]<br>at the<br>tip of<br>[[Vermiform appendix|appendix]] | ||
* Generally<br>less than<br>1 cm | |||
* Gray or <br>yellow | |||
* Well-<br>demarcated<br>firm | |||
* Intramural<br>nodules<br>that may<br>narrow or<br>obliterate<br>appendiceal<br> lumen | |||
* Proximal<br>tumors<br>may cause<br>obstruction<br>and<br>appendicitis | |||
'''Microscopic pathology:''' | '''Microscopic<br>pathology:''' | ||
*Insular growth pattern of solid islands of uniform polygonal cells with minimal pleomorphism | *Insular<br>growth<br>pattern<br>of solid<br>islands of<br>uniform<br>polygonal<br>cells with<br>minimal<br>pleomorphism | ||
*Retraction of peripheral tumor cells from stroma | *Retraction<br>of<br>peripheral<br>tumor<br>cells from<br> stroma | ||
* | *Angio-<br>lymphatic<br>invasion<br>is common | ||
*Granular eosinophilic cytoplasm with either diffusely scattered or peripherally clumped granules | *Granular<br>eosinophilic<br>cytoplasm<br>with either<br>diffusely<br>scattered<br>or<br>peripherally<br>clumped<br>granules | ||
*Two types of well differentiated tumors: EC cell (serotonin producing) and rarely L-cell (enteroglucagon or peptide YY producing) | *Two types<br>of well<br>differentiated<br>tumors:<br> EC cell <br>(serotonin<br> producing) <br>and rarely<br> L-cell<br> (enteroglucagon<br>or <br>peptide YY <br>producing) | ||
'''IHC''' | [[Immunohistochemistry|'''IHC''']]''':''' | ||
*Might be<br> positive for <br>'''S100''' | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" |Goblet cell carcinoid | | style="background: #DCDCDC; padding: 5px;" |Goblet | ||
cell | |||
carcinoid | |||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
Line 183: | Line 190: | ||
* '''CK 20''' | * '''CK 20''' | ||
* '''CK 7''' | * '''CK 7''' | ||
* Synapthosin | * [[Synapthosin|Synap- thosin]] | ||
* pancreatic polypeptide | * pancreatic polypeptide | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
* CA 125 | * [[CA-125|CA -125]] | ||
| colspan="4" style="background: #F5F5F5; padding: 5px;" |Unfortunately, compared to the other carcinoid tumors of appendix,<br> GCC is more aggressive and <br>patients with GCC generally present at higher stages.<br> Hence, in addition to<br> the above mentioned <br>general findings for appendix cancers, <br>imaging studies should <br>look for evidences of peritoneal involvement,<br> bone metastasis, lymphadenopathy, <br>and metastatic lesions<br> in ovaries and/or prostate. | | colspan="4" style="background: #F5F5F5; padding: 5px;" |Unfortunately,<br> compared to the other carcinoid tumors of appendix,<br> GCC is more aggressive and <br>patients with GCC generally present at higher stages.<br> Hence, in addition to<br> the above mentioned <br>general findings for appendix cancers, <br>imaging studies should <br>look for evidences of peritoneal involvement,<br> bone metastasis, lymphadenopathy, <br>and metastatic lesions<br> in ovaries and/or prostate. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
'''Gross pathology''': | '''Gross<br>pathology''': | ||
* No gross<br>tumor might<br>be present | |||
* Thickened<br>appendiceal<br>wall | |||
'''Microscopic appearance:''' | '''Microscopic<br>appearance:''' | ||
*GCC Generally spares mucosa and infiltrates muscularis propria and | *GCC Generally<br>spares mucosa<br>and<br>infiltrates<br>muscularis<br>propria<br>and<br>peri-<br>appendiceal<br> fat | ||
*Tumor cell clusters | *Tumor<br> cell clusters | ||
*Crypt-like structures | *Crypt-like<br> structures | ||
*Tubules of mucus-secreting cells distended with mucin resembling goblet cells | *Tubules of<br> mucus-secreting <br>cells distended<br> with mucin <br>resembling<br> goblet cells | ||
*Eosinophilic cytoplasm resembling carcinoid tumors | *Eosinophilic<br> cytoplasm <br>resembling<br> carcinoid <br>tumors | ||
*Pools of extracellular mucin | *Pools of <br>extracellular<br> mucin | ||
*Scattered Paneth cells in tumors with crypt like structures | *Scattered<br>Paneth cells<br>in tumors<br>with crypt<br>like<br>structures | ||
*Extensive perineural invasion | *Extensive<br>perineural<br>invasion | ||
*'''Carcinomatous growth pattern:''' | *'''Carcinomatous<br>growth<br>pattern:''' | ||
*Cribriform<br>growth<br>pattern,<br>solid<br>sheets of<br>infiltrating<br>signet ring<br>cells | |||
*Nuclear<br>pleomorphism | |||
*Increased<br>mitotic<br>activity | |||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
Line 242: | Line 249: | ||
modalities | modalities | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | ||
pathology | |||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele | ||
| style="background: #DCDCDC; padding: 5px;" |Mucosal | | style="background: #DCDCDC; padding: 5px;" |Mucosal | ||
[[hyperplasia]] | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
Line 260: | Line 269: | ||
* | * | ||
* low<br>attenuation<br> well<br> defined<br> mass in<br> RLQ<br>near<br>cecum | * low<br>attenuation<br> well<br> defined<br> mass in<br> RLQ<br>near<br>cecum | ||
* Inflammation<br> is the key to<br> distinguish<br> between<br> appendicitis<br> and<br> mucocele | * [[Inflammation]]<br> is the key to<br> distinguish<br> between<br> appendicitis<br> and<br> mucocele | ||
* Wall<br> thickness<br>'''does not'''<br> distinguish<br> between<br> malignant <br>and <br>benign<br> mucocele | * Wall<br> thickness<br>'''does not'''<br> distinguish<br> between<br> malignant <br>and <br>benign<br> mucocele | ||
* Intramural<br> nodule <br>is a sign of<br> neoplastic<br> lesions. <sup>4</sup> | * Intramural<br> nodule <br>is a sign of<br> neoplastic<br> lesions. <sup>4</sup> | ||
Line 272: | Line 281: | ||
* Thin<br>appendiceal<br>wall | * Thin<br>appendiceal<br>wall | ||
* A focus<br>of<br>hyper-<br>echogenicity | * A focus<br>of<br>hyper-<br>echogenicity | ||
* '''Since<br> generally<br> there is<br> no inflammation''' | * '''Since<br> generally<br> there is<br> no [[inflammation]]''' | ||
* Surrounding <br>fat<br> is normal. | * Surrounding <br>fat<br> is normal. | ||
* No peri-<br>appendiceal <br>fluid or<br>collection | * No peri-<br>appendiceal <br>fluid or<br>collection | ||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |N/A | | rowspan="4" style="background: #F5F5F5; padding: 5px;" |N/A | ||
| style="background: #F5F5F5; padding: 5px;" |Similar to hyperplastic colon polyp | | style="background: #F5F5F5; padding: 5px;" |Similar<br>to<br>hyperplastic<br>colon<br>polyp | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" |Simple or retention cyst | | style="background: #DCDCDC; padding: 5px;" |Simple | ||
or | |||
[[Mucous retention cyst|retention]] | |||
[[Mucous retention cyst|cyst]] | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
Line 287: | Line 301: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |N/A | | style="background: #F5F5F5; padding: 5px;" |N/A | ||
| style="background: #F5F5F5; padding: 5px;" |Degenerative epithelial changes because of obstruction | | style="background: #F5F5F5; padding: 5px;" |Degenerative<br>epithelial<br>changes<br>because of<br>obstruction | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" | Mucinous | | style="background: #DCDCDC; padding: 5px;" | Mucinous cyst- | ||
adenomas | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
Line 299: | Line 314: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop | | rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop | ||
pseudo-<br>myxoma<br> peritonei:<br> | [[Pseudomyxoma peritonei|pseudo-<br>myxoma<br> peritonei]]:<br> | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting<br>dullness | * [[Shifting dullness|Shifting<br>dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Histo-<br>logically<br>benign | ||
* Similar to colon adenomatous polyps or villous adnomas | * Similar<br>to<br>colon<br>adenomatous<br>polyps or<br> villous <br>adnomas | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" | Mucinous | | style="background: #DCDCDC; padding: 5px;" | Mucinous [[Cystadenocarcinoma staging|cystadeno-]] | ||
[[Cystadenocarcinoma staging|carcinomas]] | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
Line 319: | Line 335: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Glandular invasion into the stoma | * Glandular<br>invasion<br>into the<br>stoma | ||
* | * Pseudo-<br>myxoma<br>peritonei | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel<br>freq-<br>uency | ||
freq- | |||
uency | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | ||
'''symptoms''' | '''symptoms''' | ||
Line 337: | Line 350: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
physical | physical<br>exami-<br>nation<br>findings | ||
exami- | |||
nation | |||
findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA''' | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA''' | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra- | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra-<br>sounography<br> | ||
sounography | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other<br>diagnostic<br>studies<br>and<br>imaging<br>modalities<br> | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | ||
diagnostic | pathology | ||
studies | |||
and | |||
imaging | |||
modalities | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | |||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Ovarian cancer differential diagnosis|Ovarian cancer]] | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Ovarian cancer differential diagnosis|Ovarian cancer]] | ||
Line 367: | Line 365: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki><math>\downarrow</math> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki><math>\downarrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Pelvic/ abdominal pain or pressure | * Pelvic/ [[abdominal pain]] or pressure | ||
* Vaginal bleeding/ discharge | * [[Vaginal bleeding]]/ discharge | ||
* Dyspnea | * [[Dyspnea|Dyspne]]<nowiki/>a | ||
* GI disturbance | * GI disturbance | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Line 375: | Line 373: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting dullness | * [[Shifting dullness]] | ||
* Fever | * [[Fever]] | ||
* Pleural effusion | * [[Pleural effusion]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* '''Depends<br>on<br>the<br>underlying<br>etiology''' | * '''Depends<br>on<br>the<br>underlying<br>etiology''' | ||
* Iron | * Iron | ||
* HCG | * [[Human chorionic gonadotropin|HCG]] | ||
* LDH | * [[Lactate dehydrogenase|LDH]] | ||
* Calcium | * [[Calcium]] | ||
* Estrogen | * [[Estrogen]] | ||
* Progestron | * Progestron | ||
* Testos- | * [[Testosterone|Testos-<br>terone]] | ||
* AFP | * [[Alpha-fetoprotein|AFP]] | ||
* CA 125 | * [[CA-125]] | ||
* Ki 67 | * Ki 67 | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 399: | Line 397: | ||
* Pleural <br>effusion | * Pleural <br>effusion | ||
* Peritoneal<br>involvement | * Peritoneal<br>involvement | ||
* Lympha-denopathy | * [[Lymphadenopathy|Lympha-denopathy]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Adnexal <br> mass | * Adnexal <br> mass | ||
Line 418: | Line 416: | ||
* Calcification | * Calcification | ||
| style="background: #F5F5F5; padding: 5px;" | N/A | | style="background: #F5F5F5; padding: 5px;" | N/A | ||
| style="background: #F5F5F5; padding: 5px;" | Depends on the tumor type. You may find the details [[Ovarian cancer differential diagnosis|here]]. | | style="background: #F5F5F5; padding: 5px;" | Depends<br>on the<br>tumor type.<br>You may<br>find the<br>details<br>[[Ovarian cancer differential diagnosis|here]]. | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Colorectal cancer]] | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Colorectal cancer]] | ||
Line 442: | Line 440: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy''' | | style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy''' | ||
''Adeno-'' | ''[[Adenocarcinoma|Adeno-]]'' | ||
''carcinoma'' | ''[[Adenocarcinoma|carcinoma]]'' | ||
* [[Polyp|Polyps]]<br>(villous,<br>tubular,<br>tubulo-<br>villous) | * [[Polyp|Polyps]]<br>(villous,<br>tubular,<br>tubulo-<br>villous) | ||
* [[Ulcer|Ulcerating<br>polyps]] | * [[Ulcer|Ulcerating<br>polyps]] | ||
Line 451: | Line 449: | ||
* [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]]<br>or<br>fungating<br>lesions in<br>the<br> wall of<br>colon | * [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]]<br>or<br>fungating<br>lesions in<br>the<br> wall of<br>colon | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | -/+([[Carcinoid Tumor|Carcinoid tumor]]<nowiki/>s) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Anemia]] | * [[Anemia]] | ||
* Positive | * Positive<br>fecal<br>occult<br>blood<br>test | ||
* High<br>levels<br>of<br>[[CEA]] | * High<br>levels<br>of<br>[[CEA]]<br>and<br>[[CA 19-9]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*luminal<br>narrowing<br> | *luminal<br>narrowing<br> | ||
Line 463: | Line 461: | ||
*[[Metastases|Hepatic<br>metastases]], | *[[Metastases|Hepatic<br>metastases]], | ||
*Intestinal<br>perforation,<br> | *Intestinal<br>perforation,<br> | ||
*Enlarged<br>lymph<br>nodes | *[[Lymphadenopathy|Enlarged<br>lymph<br>nodes]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Tumor]]<br> mass<br> and <br>the<br> extension<br> of<br> [[tumor]] to<br> other<br> structures | * [[Tumor]]<br> mass<br> and <br>the<br> extension<br> of<br> [[tumor]] to<br> other<br> structures | ||
Line 469: | Line 467: | ||
* [[liver]],<br>[[lung]]<br>and<br>[[brain]]<br>[[Metastasis]] | * [[liver]],<br>[[lung]]<br>and<br>[[brain]]<br>[[Metastasis]] | ||
| style="background: #F5F5F5; padding: 5px;" |Generally<br>not<br>recommended:<br>may<br>evaluate<br>liver metastasis<br>or presence<br>of fluid<br>in abdominal<br>cavity, but it is <br>neither <br>sensitive<br> nor<br> specific. | | style="background: #F5F5F5; padding: 5px;" |Generally<br>not<br>recommended:<br>may<br>evaluate<br>liver metastasis<br>or presence<br>of fluid<br>in abdominal<br>cavity, but it is <br>neither <br>sensitive<br> nor<br> specific. | ||
| style="background: #F5F5F5; padding: 5px;" |PET<br>scan,<br>Endoscopy,<br>Colonoscopy, | | style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|PET<br>scan]],<br>[[Endoscopy]],<br>[[Colonoscopy]], | ||
Barium enema | [[Lower gastrointestinal series|Barium enema]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Depends on the tumor type. | * Depends<br>on the<br>tumor<br>type.<br>You will<br>find more<br>information<br>[[Colorectal cancer differential diagnosis|here]] | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Pseudomyxoma peritonei differential diagnosis|Pseudomyxoma peritonei]] | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Pseudomyxoma peritonei differential diagnosis|Pseudomyxoma]] | ||
[[Pseudomyxoma peritonei differential diagnosis|peritonei]] | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
Line 485: | Line 484: | ||
| style="background: #F5F5F5; padding: 5px;" |[[Ascites]] | | style="background: #F5F5F5; padding: 5px;" |[[Ascites]] | ||
Shifting dullness | [[Shifting dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Nonspecific | ||
* Depends | * Depends<br>on the<br>[[etiology]]<br>of the<br>disease | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Low-<br>attenuation<br>Scalloping<br> of the<br> visceral<br> surfaces<br> differentiates<br> pseudo-<br>myxoma <br>from other<br> causes of<br> | * Low-<br>attenuation<br>Scalloping<br> of the<br> visceral<br> surfaces<br> differentiates<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma]] <br>from other<br> causes of<br>[[peritonitis]]. | ||
* Typically <br>does not <br>invade<br> visceral <br>organs<br> or spread<br> by [[lymphatic]]<br> or<br> hemato-<br>genous <br>routes <br>unlike<br>mucinous<br>carcino-<br>matosis | * Typically <br>does not <br>invade<br> visceral <br>organs<br> or spread<br> by [[lymphatic]]<br> or<br> hemato-<br>genous <br>routes <br>unlike<br>mucinous<br>carcino-<br>matosis | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Charact-<br> erized <br>by a mass<br>which is<br>hypointense<br>on<br>T1-weighted<br>MRI<br>and<br>hyperintense<br>on<br>T2-weighted<br>MRI.<br>MRI has<br> better<br>sensitivity<br>in<br>detecting<br>ascites<br>fluid <br> | Charact-<br> erized <br>by a mass<br>which is<br>hypointense<br>on<br>T1-weighted<br>MRI<br>and<br>hyperintense<br>on<br>T2-weighted<br>[[Magnetic resonance imaging|MRI]].<br>[[Magnetic resonance imaging|MRI]] has<br> better<br>sensitivity<br>in<br>detecting<br>[[ascites]]<br>fluid <br>and<br>[[mucocele]]. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* The echoes<br>within<br>pseudo-<br>myxoma <br>peritonei <br>are not <br>mobile. | * The echoes<br>within<br>[[Pseudomyxoma peritonei|pseudo-<br>myxoma <br>peritonei]] <br>are not <br>mobile. | ||
* Echogenic<br>septations <br>within<br> the<br> gelatinous<br> ascites. | * Echogenic<br>septations <br>within<br> the<br> gelatinous<br> ascites. | ||
* Scalloping <br>of the<br> [[hepatic]] <br>and<br>splenic <br>margins | * Scalloping <br>of the<br> [[hepatic]] <br>and<br>splenic <br>margins | ||
| style="background: #F5F5F5; padding: 5px;" |18F-FDG<br> [[PET scan]] | | style="background: #F5F5F5; padding: 5px;" |18F-FDG<br> [[PET scan]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Depending on [[WHO]]<nowiki/>classification, whether it | * Depending<br> on<br> [[WHO]]<nowiki/> <br>classification,<br> whether it is <br>low or high <br>grade<br> with <br>cellular atypia <br>or acellular mucin. <br>( DPAM, PMCA) | ||
* Gelatinous [[ascites]] in peritoneum and [[visceral]]<nowiki/>organs,usually underneath the right hemidiaphragm, liver. | * Gelatinous<br> [[ascites]] <br>in peritoneum <br>and<br> [[visceral]]<br><nowiki/>organs,<br>usually <br>underneath<br> the right<br> hemidiaphragm,<br> liver. | ||
* Omental cake | * Omental cake | ||
[[Immunohistochemistry|'''IHC''']]''':''' | |||
*CK 20 | |||
* [[CDX2]] | |||
* [[MUC2]] | |||
* MUC5AC | |||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Carcinoid syndrome]] | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Carcinoid syndrome]] | ||
Line 514: | Line 513: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<math>\uparrow</math> | | style="background: #F5F5F5; padding: 5px;" |<math>\uparrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" |Flushing | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Flushing]] | |||
Palpitation | * [[Palpitation]] | ||
* [[Dyspnea]] | |||
Dyspnea | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* TR | ** [[Tricuspid regurgitation|TR]][[Heart murmur|murmur]] | ||
* Wheezing | ** [[Wheeze|Wheezing]] | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |Depends | | style="background: #F5F5F5; padding: 5px;" |Depends<br>on the<br>tumor<br>[[Neuroendocrine tumors laboratory findings|type]]: | ||
on the | |||
tumor [[Neuroendocrine tumors laboratory findings|type]]: | |||
* Ki67 | * Ki67 | ||
* N-terminal | * N-terminal<br>pro–B-<br>type<br>natriuretic<br>peptide | ||
* [[Substance P]] | * [[Substance P]] | ||
* [[Neurotensin]] | * [[Neurotensin]] | ||
* [[Bradykinin]] | * [[Bradykinin]] | ||
* | * Human<br>chorionic<br>gonadotropin | ||
* | * Neuro-<br>peptide L | ||
* | * Pancreatic<br>polypeptide | ||
* | * | ||
| colspan="3" style="background: #F5F5F5; padding: 5px;" |Depends on the <br>primary tumor location and type | | colspan="3" style="background: #F5F5F5; padding: 5px;" |Depends on the <br>primary tumor location and type | ||
Line 552: | Line 547: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Salt and pepper nuclei | * Salt<br> and<br> pepper<br> nuclei | ||
* Cellular uniformity | * Cellular<br> uniformity | ||
* Central ovoid nucleus | * Central <br>ovoid<br> nucleus | ||
* Presence of ribbons, trabeculae, nesting, glands, gyriform, pseudorosettes | * Presence of <br>ribbons,<br> trabeculae, <br>nesting, <br>glands,<br> gyriform,<br> pseudorosettes | ||
* Insulinoma (Amyloid deposition) | * Insulinoma <br>(Amyloid <br>deposition) | ||
* Somatostatinom (Psammoma bodies) | * Somatostatinom <br>(Psammoma <br>bodies) | ||
* Hyaline globules | * Hyaline <br>globules | ||
[[Immunohistochemistry|'''IHC''']]''':''' | |||
* Synaptophysin <br>(almost<br> always, <br>strongly <br>and <br>diffusely<br> expressed ) | |||
* | * CGA | ||
* CD56 and PGP<br>( less <br>specific) | |||
** | * PDX1 | ||
* ISL1 | |||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Appendicitis differential diagnosis|Appendicitis]] <sup>3</sup> | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Appendicitis differential diagnosis|Appendicitis]] <sup>3</sup> | ||
Line 571: | Line 567: | ||
| style="background: #F5F5F5; padding: 5px;" |[[Nausea and vomiting|Nausea<br> &<br>vomiting]],<br>decreased | | style="background: #F5F5F5; padding: 5px;" |[[Nausea and vomiting|Nausea<br> &<br>vomiting]],<br>decreased | ||
appetite | [[appetite]] | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
Line 578: | Line 574: | ||
* Rebound<br>tenderness | * Rebound<br>tenderness | ||
* Abdominal<br>guarding | * Abdominal<br>guarding | ||
* Rovsing's<br>sign | * [[Rovsing's sign|Rovsing's<br>sign]] | ||
* Psoas<br>sign | * [[Psoas sign|Psoas<br>sign]] | ||
* Obturator<br>sign | * [[Obturator sign|Obturator<br>sign]] | ||
* TR exam<br>might reveal<br>tenderness<br>in the<br>rectovesical<br>pouch | * [[Rectal examination|TR exam]]<br>might reveal<br>tenderness<br>in the<br>[[Rectovesical excavation|rectovesical<br>pouch]] | ||
* [[Tachypnea]] | * [[Tachypnea]] | ||
* Tachycardia | * Tachycardia | ||
Line 590: | Line 586: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
* Left shift | * [[Left shift]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
*Appendiceal<br> wall<br> thickening<br> /perforation | *Appendiceal<br> wall<br> thickening<br> /perforation | ||
*Peri-<br>appendiceal<br>inflammation,<br>fluid<br>accumulation,<br> | *Peri-<br>appendiceal<br>[[inflammation]],<br>fluid<br>accumulation,<br> | ||
*Fat<br>stranding | *Fat<br>stranding | ||
Line 601: | Line 597: | ||
* Dilated<br> appendix | * Dilated<br> appendix | ||
* Peri-<br>appendiceal <br> fluid<br> collection | * Peri-<br>appendiceal <br> fluid<br> collection | ||
* Distinct <br> appendix<br> wall<br> layers | * Distinct <br> [[Vermiform appendix|appendix]]<br> wall<br> layers | ||
| style="background: #F5F5F5; padding: 5px;" |[[Tc-99m]] <br> labeled <br> anti-<br> [[CD15]]<br> [[antibodies]] | | style="background: #F5F5F5; padding: 5px;" |[[Tc-99m]] <br> labeled <br> anti-<br> [[CD15]]<br> [[antibodies]] | ||
| style="background: #F5F5F5; padding: 5px;" |Evidences <br> of<br> [[inflammation]] | | style="background: #F5F5F5; padding: 5px;" |Evidences <br> of<br> [[inflammation]] | ||
Line 640: | Line 636: | ||
modalities | modalities | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | ||
pathology | |||
|} | |} | ||
<small><sup>1</sup></small> | <small><sup>1</sup></small> [[Adenocarcinoma]]<nowiki/>s usually present with appendicitis, barely they might present with [[Pseudomyxoma peritonei]]; meanwhile [[pseudomyxoma peritonei]] is more prevalent in perforated [[mucocele]], goblet cell tumor or high stages of [[Adenocarcinoma|adenocarcinoma.]] | ||
<sup>2</sup> Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to | <sup>2</sup> Generally [[Vermiform appendix|appendix]] [[Carcinoid Tumor|carcinoids]] are [[asymptomatic]], they were only become symptomatic if they [[Liver mass|metastasize to the liver,]] or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendicea[[Adenocarcinoma|l adenocarcinoma]]. Any patient with [[carcinoid syndrome]] should be evaluated for [[Carcinoid|appendix carcinoid]]<nowiki/>s. | ||
<sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer. | <sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer. | ||
<sup>4</sup> '''Imaging''' '''is not a reliable method to''' '''distinguish between neoplastic and''' ''' | <sup>4</sup> '''[[Imaging]]''' '''is not a reliable method to''' '''distinguish between [[Cancer|neoplastic]] and''' '''[[Neoplasm|non-neoplastic]] lesions''', hence every patient should undergo [[surgery]], appendectomy and [[Histopathology|histopathologic]] evaluation of the lesion | ||
<nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, AFP: Alpha | <nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, [[Alpha-fetoprotein|AFP]]: [[Alpha-fetoprotein]], [[Human chorionic gonadotropin|HCG: Human chorionic gonadotropin]], [[Lactate dehydrogenase|LDH: Lactate Dehydrogenase]], [[Carcinoembryonic antigen|CEA: Carcinoembryonic antigen]], [[CA-125|CA-125: Cancer antigen 125]], [[5-Hydroxyindoleacetic acid|5-HIAA: Urinary 5-hydroxyindoleacetic acid]] , [[Chromogranin A|CgA: Serum Chromogranin A]] ,PU: Periumbelical, TR: [[Tricuspid regurgitation]] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Surgery]] | |||
[[Category:Medicine]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Differential diagnosis]] |
Latest revision as of 13:26, 15 July 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
Differentiating appendix cancer from other Diseases
- Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
- As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype.
- Carcinoid tumors must be differentiated from other diseases that cause carcinoid syndrome sign and symptoms such as palpitation, facial flushing, and diarrhea.
- In contrast, adenocarcinomas and cystadenocarcinomas must be differentiated from other diseases that cause acute appendicitis or present with pseudomyxoma peritonei, such as colorectal cancers and appendix mucoceles.
Diseases | Clinical manifestations | Para-clinical findings | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histo-
pathology | |||||||||||||
Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities | |||
Appendix cancer | Adeno- | +/- | -/+ | <math>\downarrow</math> |
|
- | - | - |
|
|
|
Positron emission tomography (PET) |
Gross pathology:
Microscopic
IHC:
| ||
Carcinoid | +/- | - | <math>\uparrow</math> |
|
- | - | + |
Ki67: |
|
Gross pathology:
Microscopic
IHC:
| |||||
Goblet
cell carcinoid |
+ | +/- | <math>\uparrow</math> |
|
+/- | + |
|
+/- |
|
Unfortunately, compared to the other carcinoid tumors of appendix, GCC is more aggressive and patients with GCC generally present at higher stages. Hence, in addition to the above mentioned general findings for appendix cancers, imaging studies should look for evidences of peritoneal involvement, bone metastasis, lymphadenopathy, and metastatic lesions in ovaries and/or prostate. |
Gross
Microscopic
| ||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology | |
Appendix Mucocele | Mucosal | - | - | - |
|
- | +/- | N/A | - | N/A |
|
Rounded right iliac fossa mass
|
|
N/A | Similar to hyperplastic colon polyp |
Simple
or |
- | - | - | - | +/- | - | - | N/A | Degenerative epithelial changes because of obstruction | ||||||
Mucinous cyst-
adenomas |
+/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+/- | +/- | If develop | - |
| ||||||
Mucinous cystadeno- | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> | +/- | +/- | - | - |
| |||||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra- sounography |
Other diagnostic studies and imaging modalities |
Histo-
pathology | |
Ovarian cancer | +/- | +/- | +/-<math>\downarrow</math> |
|
+ | +/- | - |
|
|
|
N/A | Depends on the tumor type. You may find the details here. | |||
Colorectal cancer | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+ | +/- | Colonoscopy
Carcinoids
|
-/+(Carcinoid tumors) |
|
Generally not recommended: may evaluate liver metastasis or presence of fluid in abdominal cavity, but it is neither sensitive nor specific. |
PET scan, Endoscopy, Colonoscopy, |
| |||
Pseudomyxoma | + | + | <math>\uparrow</math><math>\downarrow</math> | Bloating | - | + | Ascites | - |
|
|
Charact- |
|
18F-FDG PET scan |
IHC: | |
Carcinoid syndrome | -/+ | - | <math>\uparrow</math> | - | - | + | Depends on the tumor type:
|
Depends on the primary tumor location and type |
|
IHC:
| |||||
Appendicitis 3 | PU, RLQ |
- | <math>\uparrow</math><math>\downarrow</math> | Nausea & vomiting, decreased |
+/- | + |
|
- |
|
Increased fluid signal on T2 weighted sequence |
Evidences of inflammation
|
Tc-99m labeled anti- CD15 antibodies |
Evidences of inflammation | ||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
frequ- f ency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology |
1 Adenocarcinomas usually present with appendicitis, barely they might present with Pseudomyxoma peritonei; meanwhile pseudomyxoma peritonei is more prevalent in perforated mucocele, goblet cell tumor or high stages of adenocarcinoma.
2 Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendiceal adenocarcinoma. Any patient with carcinoid syndrome should be evaluated for appendix carcinoids.
3 Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer.
4 Imaging is not a reliable method to distinguish between neoplastic and non-neoplastic lesions, hence every patient should undergo surgery, appendectomy and histopathologic evaluation of the lesion
*Abbreviations: RLQ: Right Lower Quadrant, AFP: Alpha-fetoprotein, HCG: Human chorionic gonadotropin, LDH: Lactate Dehydrogenase, CEA: Carcinoembryonic antigen, CA-125: Cancer antigen 125, 5-HIAA: Urinary 5-hydroxyindoleacetic acid , CgA: Serum Chromogranin A ,PU: Periumbelical, TR: Tricuspid regurgitation